Sunniva Inc.

OTC: SNNVF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#583 of 1,394 Healthcare companies by revenue63rd-percentile growth

EA Score

——

FH —DQ —GM —SS 40

v0.1 · 5/100 weight · pillars only

↑ balance-sheet leverage, workforce scale · ↓ disclosure history, market scale

Methodology →

Revenue TTM

$22.8M

Rev growth YoY (TTM)

+52.1%

Net income (FY)

-$22.4M

Employees

148

Market cap

$3.9k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$14.5M18.8M CAD2018

Net income-$22.4M-29.0M CAD2018

Operating income-$21.7M-28.1M CAD2018

Total assets$91.9M125.3M CAD2018

Liabilities$29.5M40.3M CAD2018

Equity$62.3M85.0M CAD2018

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Sunniva Inc. booked $14.5M in FY2018 revenue, growing 17% year over year — faster than most Healthcare companies we track, at a -154.6% net margin.

Peers · Healthcare

Response Genetics, Inc——Skylight Health Group Inc.——Tengion, Inc.——Nemaura Medical Inc.——

Key facts

CEOAnthony F. Holler

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: SNNVF

Employees148

IPO date2018-01-11

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.